Figure_1.tif (161.56 kB)
CONSORT diagram.
figure
posted on 2013-10-29, 02:44 authored by Michael J. Campbell, Denise Wolf, Rita A. Mukhtar, Vickram Tandon, Christina Yau, Alfred Au, Frederick Baehner, Laura van’t Veer, Donald Berry, Laura J. EssermanOf the 237 patients enrolled in the I SPY-1 trial, 221 patients were evaluable, 215 had pathology results, and 102 of these were stained for PCNA+ TAMs. All 102 cases with IHC staining for PCNA+ TAMs had Agilent gene expression array data available and 80 of the 102 cases had Affymetrix expression array data available.